Literature DB >> 26880226

Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology.

Christopher T Smith1, Jessica Weafer2, Ronald L Cowan3, Robert M Kessler4, Abraham A Palmer5, Harriet de Wit2, David H Zald3.   

Abstract

Rate of delivery of psychostimulants has been associated with their positive euphoric effects and potential addiction liability. However, information on individual differences in onset of d-amphetamine's effects remains scarce. We examined individual differences in the time to peak subjective and physiological effects and the pharmacokinetics/pharmacodynamics of oral d-amphetamine. We considered two independent studies that used different dosing regimens where subjects completed the drug effects questionnaire at multiple time points post d-amphetamine. Based on the observation of distinct individual differences in time course of drug effects questionnaire "feel", "high", and "like" ratings (DEQH+L+F) in Study 1, subjects in both studies were categorized as early peak responders (peak within 60 minutes), late peak responders (peak > 60 minutes) or nonresponders; 20-25% of participants were categorized as early peak responders, 50-55% as late peak responders and 20-30% as nonresponders. Physiological (both studies) and plasma d-amphetamine (Study 1) were compared among these groups. Early peak responders exhibited an earlier rise in plasma d-amphetamine levels and more sustained elevation in heart rate compared to late peak responders. The present data illustrate the presence of significant individual differences in the temporal pattern of responses to oral d-amphetamine, which may contribute to heightened abuse potential.
© The Author(s) 2016.

Entities:  

Keywords:  addiction; d-amphetamine; individual differences; pharmacokinetics; subjective effects

Mesh:

Substances:

Year:  2016        PMID: 26880226      PMCID: PMC5049703          DOI: 10.1177/0269881116631650

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  75 in total

1.  Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy men.

Authors:  L H Brauer; J Ambre; H De Wit
Journal:  J Clin Psychopharmacol       Date:  1996-02       Impact factor: 3.153

2.  Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.

Authors:  S H Kollins; C R Rush; P J Pazzaglia; J A Ali
Journal:  Exp Clin Psychopharmacol       Date:  1998-11       Impact factor: 3.157

3.  The rate hypothesis and agonist substitution approaches to cocaine abuse treatment.

Authors:  D A Gorelick
Journal:  Adv Pharmacol       Date:  1998

4.  Personality and the acute subjective effects of d-amphetamine in humans.

Authors:  Matthew G Kirkpatrick; Chris-Ellyn Johanson; Harriet de Wit
Journal:  J Psychopharmacol       Date:  2013-01-23       Impact factor: 4.153

Review 5.  Genetic factors modulating the response to stimulant drugs in humans.

Authors:  Amy B Hart; Harriet de Wit; Abraham A Palmer
Journal:  Curr Top Behav Neurosci       Date:  2012

6.  The influence of gastrointestinal transit on drug absorption in healthy volunteers.

Authors:  S A Riley; F Sutcliffe; M Kim; M Kapas; M Rowland; L A Turnberg
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

7.  Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans.

Authors:  C R Rush; W D Essman; C A Simpson; R W Baker
Journal:  J Clin Psychopharmacol       Date:  2001-06       Impact factor: 3.153

8.  Relationship between psychostimulant-induced "high" and dopamine transporter occupancy.

Authors:  N D Volkow; G J Wang; J S Fowler; S J Gatley; Y S Ding; J Logan; S L Dewey; R Hitzemann; J Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  The speed of cocaine delivery determines the subsequent motivation to self-administer the drug.

Authors:  Ellie-Anna Minogianis; Daniel Lévesque; Anne-Noël Samaha
Journal:  Neuropsychopharmacology       Date:  2013-07-18       Impact factor: 7.853

Review 10.  Dynamics of extracellular dopamine in the acute and chronic actions of cocaine.

Authors:  Charles W Bradberry
Journal:  Neuroscientist       Date:  2002-08       Impact factor: 7.519

View more
  5 in total

1.  Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine.

Authors:  Christopher T Smith; Linh C Dang; Ronald L Cowan; Robert M Kessler; David H Zald
Journal:  Neuropharmacology       Date:  2016-05-10       Impact factor: 5.250

2.  Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [18F]fallypride PET.

Authors:  Christopher T Smith; Linh C Dang; Leah L Burgess; Scott F Perkins; M Danica San Juan; Darcy K Smith; Ronald L Cowan; Nam T Le; Robert M Kessler; Gregory R Samanez-Larkin; David H Zald
Journal:  Psychopharmacology (Berl)       Date:  2018-10-22       Impact factor: 4.530

Review 3.  Conceptualizing Health Behaviors as Acute Mood-Altering Agents: Implications for Cancer Control.

Authors:  Genevieve F Dunton; Jonas T Kaplan; John Monterosso; Raina D Pang; Tyler B Mason; Matthew G Kirkpatrick; Sandrah P Eckel; Adam M Leventhal
Journal:  Cancer Prev Res (Phila)       Date:  2020-01-16

4.  PET imaging of dopamine-D2 receptor internalization in schizophrenia.

Authors:  J J Weinstein; E van de Giessen; R J Rosengard; X Xu; N Ojeil; G Brucato; R B Gil; L S Kegeles; M Laruelle; M Slifstein; A Abi-Dargham
Journal:  Mol Psychiatry       Date:  2017-05-16       Impact factor: 15.992

5.  Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects.

Authors:  Patrick C Dolder; Petra Strajhar; Patrick Vizeli; Felix Hammann; Alex Odermatt; Matthias E Liechti
Journal:  Front Pharmacol       Date:  2017-09-07       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.